ORYZON Strengthens Regulatory Strategy with the Appointment of Dr. Iman Barilero as Senior Advisor for Regulatory Affairs

ORYZON Strengthens Regulatory Strategy with the Appointment of Dr. Iman Barilero as Senior Advisor for Regulatory Affairs GlobeNewswire October 28, 2025 To enhance and accelerate regulatory dialogue with the FDA To provide strategic guidance across clinical development programs To bring deep expertise in CNS and immuno-oncology MADRID and CAMBRIDGE, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) […]

Advanced Flower Capital Schedules Earnings Release and Conference Call for the Third Quarter Ended September 30, 2025

(NasdaqGM:AFCG), WEST PALM BEACH, Fla., Oct. 28, 2025 (GLOBE NEWSWIRE) — Advanced Flower Capital Inc. (Nasdaq: AFCG) (“AFC”) today announced that it will release its financial results for the third quarter ended September 30, 2025, on Wednesday, November 12, 2025, before market open. Management will review AFC's financial results at 10:00 am ET via webcast

R1 Welcomes Estelle Barnes to Lead Enterprise Customer Engagement and Partnerships

R1 Welcomes Estelle Barnes to Lead Enterprise Customer Engagement and Partnerships GlobeNewswire October 28, 2025 MURRAY, Utah, Oct. 28, 2025 (GLOBE NEWSWIRE) — R1 (“R1” or the “Company”), the leader in healthcare revenue management, today announced the appointment of Estelle Barnes as the leader of R1's Enterprise Customer Engagement and Partnership function. In this role,

Provident Protection Plus Named a Top Performing Insurance Agency in the U.S. by the Independent Insurance Agents & Brokers of America for the Third Consecutive Year

(NYSE:PFS), AUGUSTA, N.J., Oct. 28, 2025 (GLOBE NEWSWIRE) — Provident Protection Plus, a full-service insurance agency that offers comprehensive insurance programs to protect businesses, their employees, and consumers, has announced that it has retained its Best Practices status for 2025, joining an elite group of independent insurance agencies for the second time in a row

Esperion to Host Virtual Investor Key Opinion Leader Event Highlighting Significant Unmet Need in Statin Intolerance on Tuesday, November 11, 2025, at 2:00 p.m. ET.

(NasdaqGM:ESPR), – Leading Cardiovascular Physician Experts to Explore Real-World Challenges and Impact on Patient Outcomes – ANN ARBOR, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced it will host a virtual key opinion leader (KOL) event for investors to discuss the clinical and real-world challenges of statin intolerance, its impact on

Tronox Holdings plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TROX

Tronox Holdings plc Sued for Securities Law Violations – Contact the DJS Law Group to Discuss Your Rights – TROX GlobeNewswire October 28, 2025 LOS ANGELES, Oct. 28, 2025 (GLOBE NEWSWIRE) — The DJS Law Group reminds investors of a class action lawsuit against Tronox Holdings plc (“Tronox” or “the Company”) (NYSE: TROX) for violations

Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

Nautilus Biotechnology Reports Third Quarter 2025 Financial Results GlobeNewswire October 28, 2025 SEATTLE, Oct. 28, 2025 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Business Highlights Continued progress was made

STRATA Skin Sciences Announces COFEPRIS Clearance of TheraClear(R) in Mexico and First Commercial Placements

(NASDAQ:SSKN), HORSHAM, Pa., Oct. 28, 2025 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a global leader in in-office dermatologic technologies for the treatment of skin conditions such as acne, psoriasis, and vitiligo, today announced that its TheraClearX(R) acne treatment system has received regulatory clearance from the Mexican health authority, COFEPRIS (Comision Federal para

Targeted Genomics Launches CeliacDx Consumer-Initiated Testing Service

IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Targeted Genomics LLC, developer of GlutenID, the only U.S. Food and Drug Administration (FDA) cleared test for celiac genetics, today announced the launch of their consumer-initiated laboratory testing service, CeliacDx designed to address the hidden epidemic of undiagnosed celiac disease. Celiac disease is the most common intestinal

Lula Commerce Raises $8 Million Series A to Power the Next Generation of Digital Retail

Lula Commerce Raises $8 Million Series A to Power the Next Generation of Digital Retail Lula's AI-powered e-commerce suite helps more than 2,000 retailers unlock full digital potential with enterprise-grade order-ahead, pickup, and delivery solutions GlobeNewswire October 28, 2025 PHILADELPHIA, Oct. 28, 2025 (GLOBE NEWSWIRE) — Lula Commerce, the leading provider of AI-powered digital commerce

Scroll to Top